Limit this search to....

Skin Carcinogenesis in Man and in Experimental Models Softcover Repri Edition
Contributor(s): Hecker, Erich (Editor), Zur Hausen, H. (Foreword by), Jung, E. G. (Editor)
ISBN: 3642848834     ISBN-13: 9783642848834
Publisher: Springer
OUR PRICE:   $104.49  
Product Type: Paperback - Other Formats
Published: February 2012
Qty:
Additional Information
BISAC Categories:
- Medical | Oncology - General
- Medical | Dermatology
Dewey: 616.994
Series: Recent Results in Cancer Research
Physical Information: 0.8" H x 6.14" W x 9.21" (1.19 lbs) 364 pages
 
Descriptions, Reviews, Etc.
Publisher Description:
The detection of cancer risk factors and their possible avoid- ance would most effectively contribute to the fight against cancer. Research in these areas depends to a substantial degree on in vivo experimental animal models and on epide- miologic studies, including data from cancer registries. When the Deutsches Krebsforschungszentrum was founded in 1964, its division "Mechanisms of Tumorigenesis" and a number of other divisions became engaged in research on chemical carcinogenesis of the skin, mainly using the mouse skin as an experimental model. Their interest orig- inated in part from investigations of the new and at that time controversial pathogenic principle of conditional car- cinogens as represented by certain tumor promoters which are per se noncarcinogenic. During the past 25 years, conditional carcinogens in terms of tumor promoters were established as anew, nonclassical category of cancer risk factors besides the classical solitary carcinogens. In the course of this exciting period, scientists of our center started cooperative programs with clinical dermato- logists of the University of Heidelberg at the Clinics of Dermatology in Heidelberg and Mannheim, to extend the scope of their investigations into clinical oncology and to contribute by experimental approaches to solving problems in clinical oncology. This led to a gradual shift from mere animal studies to the more direct analyses of human tumors and opened up for us a new phase of research.